TABLE 1.
Purification method (from barium-adsorbed plasma) | n | Zn/mol | Mg/mol | Ca/mol | IC50 (μM)a | PS-direct (1/IC50) |
---|---|---|---|---|---|---|
Immunoaffinity methods | 7 | 1.4 ± 0.6 | 0.9 ± 0.6 | 8.5 ± 2.2 | 0.13 ± 0.06 | 7.7 |
MonoQ/EDTA + monoQ/Ca2+b | 2 | 0.25 ± 0.05 | 0.7 ± 0.1 | 7.5 ± 0.3 | ≥2c | ≤0.5 |
Commercial, unspecified | 3 | 0.1 ± 0.1 | 0.6 ± 0.3 | 7.0 ± 2.2 | >2 | <0.5 |
Hexyl agarose, heparin sepharose | 4 | 0.8 ± 0.5 | 0.9 ± 0.2 | 7.8 ± 1.9 | 0.14 ± 0.04 | 7.1 |
[PS] required to inhibit by 50% the rate of thrombin generated in the standardized prothrombinase assay.
MonoQ chromatography: first with a salt gradient in the presence of EDTA; second, with a gradient of CaCl2. Second preparation employed a similar Fast Flow Q resin, with EDTA, then CaCl2 (16).
Highest [PS] tested was 2 μM, which is 6-fold higher than the plasma [PS].